Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2487389 | Journal of Pharmaceutical Sciences | 2008 | 6 Pages |
Abstract
Children need medicines that are properly designed and formulated specifically for pediatric use. However, the majority of medicines prescribed for children have insufficient clinical data to support pediatric use or to determine how children will react to such medicines. In particular, children living with HIV/AIDS have limited access to pediatricâspecific antiretroviral drugs used to fight the disease. Recent improvements to U.S. and European pediatric drug testing laws may help generate more drugs tested and approved for children, but more must be done to ensure that children do not lag behind in access to lifesaving AIDS medicines, particularly in resourceâpoor countries. © 2008 WileyâLiss, Inc. and the American Pharmacists Association J Pharm Sci 97:5074-5079, 2008
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Pamela W. Barnes,